Xiaoyu Jia

Selection of the initial design for the two-stage continual reassessment method

Anastasia Ivanova, Xiaoyu Jia, Shing M Lee, 2017, Journal of biopharmaceutical statistics.

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.

Tomasz Burzykowski, Arturo Molina, Marc Buyse, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.

Alexia Iasonos, Xiaoyu Jia, Deborah Schrag, 2009, Journal of the National Cancer Institute.

A Postoperative Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas After Limb-Sparing Surgery Without Adjuvant Radiation

Li-Xuan Qin, Xiaoyu Jia, Samuel Singer, 2012, Annals of surgery.

A simulation study to evaluate the impact of the number of lesions measured on response assessment.

Lawrence H. Schwartz, Mithat Gönen, Xiaoyu Jia, 2009, European journal of cancer.

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data.

Xiaoyu Jia, Glenn Heller, Johann S de Bono, 2009, The Lancet. Oncology.